Navigation Links
Flextronics Announces Change in Control Repurchase Offer for Solectron's 0.50% Senior Convertible Notes
Date:10/31/2007

tible into a cash payment of $402.41 per $1,000 principal amount, are not currently convertible and Solectron makes no assurances that the Convertible Notes will become convertible again at any time prior to their maturity on February 15, 2034.

Holders of Convertible Notes should carefully read the Change in Control Repurchase Notice issued by Solectron, as it contains important information regarding the procedures to be followed and timing for Solectron's repurchase of the Convertible Notes. Holders of Convertible Notes may obtain copies of the Change in Control Repurchase Notice and delivery instructions for the Convertible Notes by contacting U.S. Bank National Association at (800) 934-6802.

About Flextronics

Headquartered in Singapore (Singapore Reg. No. 199002645H), Flextronics is a leading Electronics Manufacturing Services (EMS) provider focused on delivering complete design, engineering and manufacturing services to automotive, computing, consumer digital, industrial, infrastructure, medical and mobile OEMs. With the acquisition of Solectron, pro forma fiscal year 2007 revenues from continuing operations are more than US$30.0 billion. Flextronics helps customers design, build, ship, and service electronics products through a network of facilities in 35 countries on four continents. This global presence provides design and engineering solutions that are combined with core electronics manufacturing and logistics services, and vertically integrated with components technologies, to optimize customer operations by lowering costs and reducing time to market. For more information, please visit http://www.flextronics.com.


'/>"/>
SOURCE Flextronics International Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ntinelleMedicalInc.,aleadingmanufacturerofMagnetic...entificInc.,aleadingproviderofsoftwareenablingtech...t4DAdvancedVisualizationsoftware. ,, Thisinnova...tbasedmedicalimagingofferinginthemarket.CalgarySci...taccess-requiringnosoftwaredownload,andrunsonanyMa...
(Date:11/25/2009)...anksgivingmealswillbedeliveredtoapproximately1,000...aithInAction/VolunteerActionforAging,aprogramopera...Plan.Formorethan17yearstheseorganizationshavegathe...alstoseniorsinneedinLongBeach,Lakewood,SignalHill,..., "Ourwarmholidaymealsaredeliveredtopeoplewhohavem...
(Date:11/25/2009).../--TheBlackAIDSInstituterecentlyheldBoardofDirecto..., ThenewBoardMembersareahighlydiversegroupoflea...rnmenthealthprograms,editorial,andbusinessentrepre...backgroundsincludingbothheterosexualandgayBlackmen...ngmultipleagegroups. ,, (Photo: http://www.news...
(Date:11/25/2009)...dPressJoinEfforttoEducate ,, MEMPHIS,Tenn.,Nov...ipolarFoundationandtheMedicAlertFoundationreceivea...whichisnowbeingwidelyacceptedasapreventivehealthca...arFoundationreceivedaproclamationofendorsementviaF...ianaMitchLandrieu.TheNationalBipolarFoundationstat...
(Date:11/25/2009)...cally significant survival benefit from adjuvant t...R)-positive tumors had high levels of phosphorylat...according to a brief communication published onlin...er Institute . , Approximately 50% of breast car...udies have shown that ER-alpha S118-P is required ...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3
... the thickness of the grey matter in the cortical ...ed thinning// of cortical region of the brain. Mai...rain is necessary for the proper functioning of th...ive and emotional processing, the researchers repo...
...educe world energy demand should it evolve into a ...ibly by more than 1-million barrels a day//. Wo...ording to data issued by the US Energy Information...by well over 1-million barrels per day,” the US in...
... a Singaporean, who had a bone marrow transplant i...ant operation without taking drugs to prevent reje... kidney failure four years ago. Two years later, d... Department of Medicine (NUH), "MDS is a pre-leuke...
...d are advised to be consumed; in the same league a...rient supplements help fight cancer even though th...particularly when you want to sell nutrition suppl...ion, helped save his neighbor known as “D.H.” with...
...d of trauma care are very few compared to other me...are would help in improving emergency treatments a...f deaths caused by accidents//. More than 10,...s, writing in this week's BMJ, argue that there is...
...rnia are finding out a new theory on the formation...hich connect other brain regions forming a new pro...eet of around 10 billion neurons divided into dist...haped by the environment? The protomap and protoco...
Other Medicine News:Health News:Meditation Maintains And Thickens The Grey Matter Of The Brain 2Health News:Bird Flu Likely To Reduce World Energy Demand 2Health News:Medical Breakthrough - Kidney Transplant Recipient Survives Without Drugs 2Health News:Another Benefit For Human Health Attributed To Omega-3-Fats 2Health News:Scientists breaking theory of cortex formation 2
(Date:11/25/2009)...NEY,Nov.25/PRNewswire-FirstCall/--HeartWareInterna...orandprovideroflessinvasive,miniaturizedcirculator...dvancedheartfailure,todayannouncedthatitisschedule...affrayHealthCareConferenceat8:00amESTonWednesday,D...PalaceHotel,December1-2. ,, AlivewebcastoftheCo...
(Date:11/24/2009)...wswire/-- ,, WHAT:RomHoubens,aBelgianmanthought...wasactuallyfullyconsciousandawakeduringthattimeand...oxEyeMaxwasfeaturedinthesegmenttoillustratehowpeop...communication. ,, WHEN:GoodMorningAmerica-- Tue...ch.com ,, WHO:RomHoubenswasanengineeringstu...
(Date:11/24/2009)...PRNewswire-FirstCall/--Vermillion,Inc.(VRML)(PinkS...anizationandDisclosureStatementtoday,November24,20...tofDelaware.AhearingtoconsiderapprovaloftheDisclos...withthehearingontheconfirmationofthePlanscheduledf...payallclaimsinfull.ThePlanisexpected,ifapproved,to...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Scientists pinpoint protein link to fat storage 9969 1Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 1Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 2Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 3Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 4Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 1Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 2Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 3Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 4
...ificantly Improved Key PSG Parameters of Sleep Mai...tudy Ongoing -, SAN DIEGO, June 12 Arena Pharmac...t Dr. Thomas Roth of Henry Ford,Hospital presented...l of,APD125 for the treatment of insomnia in an or...ing of the Associated Professional Sleep Societies...
...GAITHERSBURG, Md., June 12 ,Micromet, Inc. (Nasdaq...irst,patient has started treatment in a multi-cent...ng BiTE(R) antibody blinatumomab (MT103/MEDI-538) ...a (ALL). Blinatumomab is a T,cell engaging antibod...sed,on B cells. The clinical development program f...
Other Medicine Technology:Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 2Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 3Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 4Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 5Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 6Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 2Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 3Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 4Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 5Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 6
Ultrafin™ Stirrup
6"H Plexiglass Armshield
Armboards
3D/SwingerOperating Table Clamp
Medicine Products: